Myeloma Canada’s 2025 Aldo Del Col Research Grant: Four Projects Advancing Myeloma Treatment

Published on May 5, 2026

Myeloma Canada’s 2025 Aldo Del Col Research Grant: Four Projects 

What does the future of myeloma research look like? Find out how Canadian researchers are shaping it. Supported by the 2025 Aldo Del Col Research Grant, named in honour of Myeloma Canada's co-founder, four Canadian researchers are working toward a future where life is uninterrupted by myeloma.

Learn more:
https://myeloma.ca/2026/04/16/myeloma-canadas-2025-aldo-del-col-research-grant-four-projects-advancing-myeloma-treatment/

Other news

📢PRESS RELEASE: National reimbursement negotiations for Carvykti® terminated without agreement, devastating Canadians with myeloma

September 30, 2025
Dear community,The following is a press release issued by Myeloma Canada in the wake of learning that the pan-Canadian Pharmaceutical Alliance (pCPA) has terminated reimbursement negotiations – without agreement – for Carvykti®, an extremely promising new CAR T-cell therapy for myeloma patients. This issue will be an ongoing campaign and is not likely to be resolved in the short term as reimbursem